NCT04801771View on ClinicalTrials.gov

Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

February 28, 2027

Study Completion Date

September 30, 2027

Conditions
Down SyndromeObstructive Sleep Apnea
Interventions
DEVICE

Inspire Upper Airway Stimulation (UAS) System

The Inspire UAS System is an implantable device that provides hypoglossal nerve stimulation for the treatment of obstructive sleep apnea.

Trial Locations (8)

15224

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

30329

Children's Healthcare of Atlanta/ Emory University School of Medicine, Atlanta

32507

Children's Hospital of the King's Daughters/East Virginia Medical School, Norfolk

45229

Cincinnati Childrens Hospital, Cincinnati

53705

University of Wisconsin School of Medicine and Public Health, Madison

75207

University of Texas Southwestern/Children's Hospital of Dallas, Dallas

02114

Massachusetts General Hospital (Mass Eye & Ear Infirmary), Boston

Sponsors
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Inspire Medical Systems, Inc.

INDUSTRY

NCT04801771 - Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter